27 January 2016 - The outcomes from the December 2016 PBAC meeting are now available.

The PBAC recommended the following medicines:

• Adalimumab (Humira)
  
• Chloramphenicol (Chlorsig)
  
• Everolimus (Certican)
  
• Glyceryl trinitrate (Nitrostat)
  
• Naloxone hydrochloride (Prenoxad)
• Pirfenidone (Esbriet)
  

Read PBAC outcomes